Srivatsan Kidambi

srivatsan.kidambi(at)gmail.com

Hometown: Chennai, India
Undergraduate Institution:
University of Madras, India

Interests: Reading, tennis, gym.

Project title: Engineering Invitro cellular microenvironment using polyelectrolyte multilayer films to control cell adhesion and for drug delivery applications

Project Description: I developed highly customizable polyelectrolyte multilayer (PEM) thin films to engineer in vitro cellular microenvironments to control cell adhesion and for drug delivery applications. PEM films were engineered to control the adhesion of primary hepatocytes and primary neurons without the aid of adhesive proteins/ligands. The differential cell attachment and spreading of primary hepatocytes and neurons on poly(diallyldimethylammoniumchloride) (PDAC) and sulfonated polystyrene (SPS) surfaces was capitalized to make patterned co-cultures of primary hepatocytes/fibroblasts and primary neurons /astrocytes on the PEM surfaces. In addition, I developed self-assembled monolayer (SAM) patterns of m-d-poly(ethylene glycol) (m-dPEG) acid molecules onto PEMs. The created m-dPEG acid monolayer patterns on PEMs acted as resistive templates, and thus prevented further deposits of consecutive poly(anion)/poly(cation) pairs of charged particles and resulted in the formation of three-dimensional (3-D) patterned PEM films or selective particle depositions atop the original multilayer thin films. These new patterned and structured surfaces have potential applications in microelectronic devices and electro-optical and biochemical sensors. The PEG patterns developed are tunable at certain salt conditions and be removed from the PEM surface without affecting the PEM layers underneath the patterns. These removable surfaces provide an alternative method to form patterns of multiple particles, proteins and cells. This new approach provides an environmentally friendly and biocompatible route to designing versatile salt tunable surfaces. Finally, I illustrated the use of PEM films to engineer aptamer and siRNA based drug delivery systems.
PI: Christina Chan and Ilsoon Lee

|